Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals

被引:27
|
作者
Ribas, SG
Ondoa, P
Schüpbach, J
van der Groen, G
Fransen, K
机构
[1] Inst Trop Med, B-2000 Antwerp, Belgium
[2] Univ Zurich, Swiss Natl Ctr Retroviruses, Zurich, Switzerland
关键词
HIV-1; RNA; viral load; heat-denatured p24 antigen; HIV subtypes;
D O I
10.1016/S0166-0934(03)00219-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for monitoring disease progression in HIV seropositive patients in developing countries. Only a few data on the clinical validation of the test are available for HIV-1 non-subtypes B viruses that represent the vast majority of virus circulating in Africa. The present study was undertaken to evaluate and compare the performance of a heat-denatured signal-amplified p24 assay for the determination of p24 viral load in the plasma of individuals infected with different subtypes of HIV-1 and using the RT-PCR-based RNA viral load test as the gold standard. A total of 120 plasma samples from individuals infected with HIV-1 strains belonging to group M (subtypes A --> H) and group O, as well as recombinant strains, were tested in parallel with the heat-denatured signal-amplified p24 assay and the RNA viral load. Plasma p24 levels appeared to be correlated significantly with the plasma RNA viral loads (R = 0.751, P < 0.0001). The heat-denatured p24 antigen assay was capable of measuring the plasma level of p24 derived from all the HIV-1 subtypes and recombinants selected for this study, in contrast to the RNA viral load test which lacked sensitivity towards HIV-1 group O. The heat-denatured signal-amplified p24 assay is a reliable, sensitive and a more affordable tool that can be used for the follow-up of patients infected with B and non-B subtypes as well as recombinant forms of HIV-1 in developing countries. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [31] HIV-1(Human immunodeficiency virus type1)中和抗体研究进展
    黄钦
    曹韵贞
    国外医学病毒学分册., 2000, (03) : 86 - 88
  • [32] Human immunodeficiency Virus Type 1 Evolution in Non-B Subtypes
    Dimitrios, Coutsinos
    Mark, Waiberg A.
    NEW APPROACHES IN CORONARY ARTERY DISEASE: PROCEEDINGS OF THE 8TH INTERNATIONAL CONGRESS ON CORONARY ARTERY DISEASE, 2009, : 63 - 68
  • [33] Human Immunodeficiency Virus Type 1 Evolution in Non-B Subtypes
    Coutsinos, Dimitrios
    Mark, Wainberg A.
    26TH INTERNATIONAL CONGRESS OF CHEMOTHERAPY AND INFECTION (ICC), 2009, : 63 - 68
  • [34] Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes
    Li, Peilin
    Ruel, Theodore
    Fujimoto, Katsuya
    Hatano, Hiroyu
    Yukl, Steven
    Eller, Leigh Anne
    Liegler, Teri
    Kamya, Moses
    Gassasira, Anne
    Dorsey, Grant
    Rosenthal, Philip J.
    Havlir, Diane V.
    Wong, Joseph K.
    JOURNAL OF VIROLOGICAL METHODS, 2010, 170 (1-2) : 115 - 120
  • [35] Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype
    Sarr, AD
    Sankalé, JL
    Hamel, DJ
    Travers, KU
    Guèye-Ndiaye, A
    Essex, M
    Mboup, S
    Kanki, PJ
    VIROLOGY, 2000, 268 (02) : 402 - 410
  • [36] A cytopathic infectivity assay of human immunodeficiency virus type 1 in human primary macrophages
    Wu, SC
    Spouge, JL
    Merges, MJ
    Conley, SR
    Nara, PL
    JOURNAL OF VIROLOGICAL METHODS, 1996, 59 (1-2) : 45 - 55
  • [37] Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton
    Bukrinskaya, A
    Brichacek, B
    Mann, A
    Stevenson, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) : 2113 - 2125
  • [38] Human Cytomegalovirus Enhances Placental Susceptibility and Replication of Human Immunodeficiency Virus Type 1 (HIV-1), Which May Facilitate In Utero HIV-1 Transmission
    Johnson, Erica L.
    Boggavarapu, Sahithi
    Johnson, Elan S.
    Lal, Asim A.
    Agrawal, Parth
    Bhaumik, Siddhartha Kumar
    Murali-Krishna, Kaja
    Chakraborty, Rana
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (09) : 1464 - 1473
  • [39] Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury
    Guha, Debjani
    Wagner, Marc C. E.
    Ayyavoo, Velpandi
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [40] Inhibition of Human Immunodeficiency Type 1 Virus (HIV-1) Life Cycle by Different Egg White Lysozymes
    Mandana Behbahani
    Mokhtar Nosrati
    Hassan Mohabatkar
    Applied Biochemistry and Biotechnology, 2018, 185 : 786 - 798